Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder-Reply
- PMID: 35819427
- DOI: 10.1001/jama.2022.8349
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder-Reply
Comment on
-
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder.JAMA. 2022 Jul 12;328(2):213-214. doi: 10.1001/jama.2022.8352. JAMA. 2022. PMID: 35819431 No abstract available.
-
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder.JAMA. 2022 Jul 12;328(2):213. doi: 10.1001/jama.2022.8346. JAMA. 2022. PMID: 35819432 No abstract available.
